GMM Pfaudler Limited has informed the Exchange regarding a press release dated May 21, 2025, titled "Press Release on the Audited Standalone and Consolidated Financial Results of GMM Pfaudler Limited ( the Company ) for the year ended March 31, 2025".
GMMPFAUDLR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GMM Pfaudler reported FY25 consolidated revenue of ₹3,199 crore, down 7% year-on-year, with EBITDA of ₹381 crore (down 20%) and PAT of ₹100 crore. Q4 FY25 showed a recovery with revenue up 9% to ₹807 crore and EBITDA up 4% to ₹93 crore. Order intake for FY25 grew 3% to ₹3,102 crore, while order backlog stood at ₹1,636 crore (down 3%). The India business performed strongly in Q4 with revenue of ₹252 crore and EBITDA margin of 17.4%, and the opening order backlog for FY26 is 20% higher at ₹549 crore. The company is optimising its global manufacturing footprint — closing sites in Leven (UK) and Hyderabad, and setting up a new low-cost facility in Poland. Free cash flow improved sharply to ₹318 crore. A final dividend of ₹1 per share has been recommended, taking total FY25 dividend to ₹2 per share.
Mixed results for shareholders — the full-year numbers show a revenue and earnings decline due to weakness in chemical/pharma end markets and US tariff uncertainty, but Q4 trends, strong India performance, higher FY26 opening backlog, and improving cash flows suggest a potential recovery. The dividend and cost-optimisation measures are positives, though one-time restructuring costs (especially the ₹47.7 crore Leven UK site closure) weigh on reported PAT.